Your browser doesn't support javascript.
loading
Therapeutic plasma exchange in pediatric intensive care: Indications, results and complications.
Sik, Guntulu; Demirbuga, Asuman; Annayev, Agageldi; Akcay, Arzu; Çitak, Agop; Öztürk, Gülyüz.
Afiliação
  • Sik G; Acibadem Mehmet Ali Aydinlar University, School of Medicine, Department of Pediatric Intensive Care, Istanbul, Turkey.
  • Demirbuga A; Acibadem Mehmet Ali Aydinlar University, School of Medicine, Department of Pediatric Intensive Care, Istanbul, Turkey.
  • Annayev A; Acibadem Mehmet Ali Aydinlar University, School of Medicine, Department of Pediatric Intensive Care, Istanbul, Turkey.
  • Akcay A; Acibadem Mehmet Ali Aydinlar University, Pediatric Bone Marrow Transplantation Uni, Istanbul, Turkey.
  • Çitak A; Acibadem Mehmet Ali Aydinlar University, School of Medicine, Department of Pediatric Intensive Care, Istanbul, Turkey.
  • Öztürk G; Acibadem Mehmet Ali Aydinlar University, Pediatric Bone Marrow Transplantation Uni, Istanbul, Turkey.
Ther Apher Dial ; 24(2): 221-229, 2020 Apr.
Article em En | MEDLINE | ID: mdl-31922326
Therapeutic plasma exchange (TPE) is an effective treatment method in selective indications. Secondary to access and technical features, it is more difficult to apply in pediatric population than adults. The aim of this study is investigate safety, clinical indications, and results of this method in critically ill pediatric patients who need TPE treatment. All of the TPE procedures performed in a pediatric intensive care unit providing tertiary care during 4 years (2015-2019) were evaluated retrospectively. TPE procedures (635) were performed for 135 patients. Median age was 34 months (10-108). Ninety-seven patients had mechanical ventilation support. Sepsis with multiple organ failure was the most frequent indication and accounted for 44.4% (n = 60) of the indications followed by hematological and neurological diseases (19.2% and 9.6% respectively). TPE was performed alone in 469 cases (73.9%), in combination with continuous renal replacement therapy in 154 cases (24.2%), and additional to extracorporeal membrane oxygenation in 12 cases (1.9%). Hematological disease and sepsis subgroups had the highest intubation rate, mechanical ventilation period, PRISM score, organ failure count, and mortality. Fresh frozen plasma (FFP) was the most frequently used replacement fluid in 90.4% of the procedures. The most frequent anticoagulant used in TPE was acid citrate dextrose solution (79.3%). Procedural complications were detected in 104 cases (16.3%) and occurred during TPE sessions. Overall survival rate was 78.5%. We found that the non-survivor group had significantly higher rates of organ failures (P = 0.0001), higher PRISM scores on admission (P = 0.0001), and higher rates of invasive ventilation support needed (P = 0.012). TPE is a treatment method which can be safely provided in healthcare facilities with necessary medical and technical requirements. Although it is riskier to provide such treatment to critically ill children, complications can be minimized in experienced healthcare facilities. Overall results are good and can vary depending on indication.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Troca Plasmática / Oxigenação por Membrana Extracorpórea / Unidades de Terapia Intensiva Pediátrica / Terapia de Substituição Renal Contínua Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Troca Plasmática / Oxigenação por Membrana Extracorpórea / Unidades de Terapia Intensiva Pediátrica / Terapia de Substituição Renal Contínua Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article